Variant report
Variant | esv13660 |
---|---|
Chromosome Location | chr22:27704015-27704564 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs375241619 | chr22:27704025-27704026 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs192740560 | chr22:27704028-27704029 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs115349529 | chr22:27704033-27704034 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs182368593 | chr22:27704042-27704043 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs551062820 | chr22:27704047-27704048 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs188459141 | chr22:27704069-27704070 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs540045453 | chr22:27704097-27704098 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs552066631 | chr22:27704098-27704099 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs567204246 | chr22:27704128-27704129 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs192684075 | chr22:27704213-27704214 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs555445444 | chr22:27704231-27704232 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs573674066 | chr22:27704234-27704235 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs73430465 | chr22:27704248-27704249 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs556228747 | chr22:27704263-27704264 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs144110208 | chr22:27704292-27704293 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs545639247 | chr22:27704293-27704294 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs544820922 | chr22:27704297-27704298 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs185432136 | chr22:27704317-27704318 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs553636537 | chr22:27704333-27704334 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs146477520 | chr22:27704354-27704355 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs140915739 | chr22:27704365-27704366 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs562708757 | chr22:27704371-27704372 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs561706419 | chr22:27704374-27704375 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529291563 | chr22:27704421-27704422 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs10483133 | chr22:27704433-27704434 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs563013713 | chr22:27704438-27704439 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533346309 | chr22:27704454-27704455 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs713818 | chr22:27704503-27704504 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Velocardiofacial syndrome | 20111667 | CNVD |
Medulloblastoma | 21979893 | CNVD |
sporadic solitary meningiomas | 19589153 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Congenital heart defect | 22511896 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Seminomas | 18059402 | CNVD |
Cancer | 16751803 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Metachromatic leukodystrophy | 18421352 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Breast cancer | 21858162 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Ovarian cancer | 22174824 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21785460 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
Lung cancer | 18438408 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
abnormal development | 18461090 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17142309 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Cat eye syndrome | 16708226 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Schizophrenia | 19521646 | CNVD |
Schizophrenia | 18990708 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr22:27697000-27705800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr22:27698600-27706200 | Weak transcription | Brain Germinal Matrix | brain |
3 | chr22:27703400-27706200 | Weak transcription | Fetal Brain Female | brain |
4 | chr22:27703400-27706800 | Weak transcription | Fetal Intestine Large | intestine |
5 | chr22:27703600-27704600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
6 | chr22:27703600-27706200 | Enhancers | Fetal Muscle Leg | muscle |
7 | chr22:27703600-27706800 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
8 | chr22:27703800-27704600 | Enhancers | Adipose Nuclei | Adipose |
9 | chr22:27703800-27705000 | Weak transcription | Fetal Brain Male | brain |
10 | chr22:27704000-27704200 | Enhancers | Right Atrium | heart |
11 | chr22:27704000-27705800 | Weak transcription | Ovary | ovary |
12 | chr22:27704200-27704600 | Enhancers | Fetal Stomach | stomach |
13 | chr22:27704200-27708600 | Weak transcription | Right Atrium | heart |